Cargando…

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial

BACKGROUND: Patients with unprovoked (i.e., without the presence of apparent transient risk factors such as recent surgery) venous thromboembolism (VTE) are at risk of recurrence if anticoagulants are stopped after 3–6 months, yet their risk remains heterogeneous. Thus, prolonging anticoagulant trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geersing, Geert-Jan, Hendriksen, Janneke M. T., Zuithoff, Nicolaas P. A., Roes, Kit C., Oudega, Ruud, Takada, Toshihiko, Schutgens, Roger E. G., Moons, Karel G. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319277/ https://www.ncbi.nlm.nih.gov/pubmed/32589630 http://dx.doi.org/10.1371/journal.pmed.1003142

Ejemplares similares

Clinical characteristics associated with diagnostic delay of pulmonary embolism in primary care: a retrospective observational study
por: Hendriksen, Janneke M T, et al.
Publicado: (2017)

Real-life impact of clinical prediction rules for venous thromboembolism in primary care: a cross-sectional cohort study
por: van Maanen, Rosanne, et al.
Publicado: (2020)

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
por: van den Dries, Carline J, et al.
Publicado: (2017)

Decisions to Withhold Diagnostic Investigations in Nursing Home Patients with a Clinical Suspicion of Venous Thromboembolism
por: Schouten, Henrike J., et al.
Publicado: (2014)

Search Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance Systematic Reviews
por: Geersing, Geert-Jan, et al.
Publicado: (2012)

Correction: Search Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance Systematic Reviews
por: Geersing, Geert-Jan, et al.
Publicado: (2012)

Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis
por: Schouten, Henrike J, et al.
Publicado: (2013)

Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis
por: Geersing, G J, et al.
Publicado: (2009)

Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis
por: Schouten, Henrike J, et al.
Publicado: (2012)

Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
por: Matos, Jason D., et al.
Publicado: (2018)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis
por: Geersing, G J, et al.
Publicado: (2014)

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2022)

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care
por: Hendriksen, Janneke M T, et al.
Publicado: (2015)

Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial
por: van den Dries, Carline J, et al.
Publicado: (2020)

Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study
por: Geersing, Geert-Jan, et al.
Publicado: (2012)

Optimal duration of anticoagulation in patients with venous thromboembolism
por: Prandoni, Paolo, et al.
Publicado: (2011)

Advantages of the nested case-control design in diagnostic research
por: Biesheuvel, Cornelis J, et al.
Publicado: (2008)

Outlier classification performance of risk adjustment methods when profiling multiple providers
por: Brakenhoff, Timo B., et al.
Publicado: (2018)

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
por: van Doorn, Sander, et al.
Publicado: (2018)

The Patient Health Questionnaire-9 for detection of major depressive disorder in primary care: consequences of current thresholds in a crosssectional study
por: Zuithoff, Nicolaas PA, et al.
Publicado: (2010)

Reporting and Methods in Clinical Prediction Research: A Systematic Review
por: Bouwmeester, Walter, et al.
Publicado: (2012)

Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
por: den Exter, Paul L., et al.
Publicado: (2022)

Meta-analyses triggered by previous (false-)significant findings: problems and solutions
por: Schuit, Ewoud, et al.
Publicado: (2015)

Managing the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness Analysis
por: van den Dries, Carline J., et al.
Publicado: (2023)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)

Thromboembolism and anticoagulation after Fontan surgery
por: Viswanathan, Sangeetha
Publicado: (2016)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Validation and impact of a simplified clinical decision rule for diagnosing pulmonary embolism in primary care: design of the PECAN prospective diagnostic cohort management study
por: van Maanen, Rosanne, et al.
Publicado: (2019)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
por: Alexander, Peter, et al.
Publicado: (2021)

Surfactants tailored by the class Actinobacteria
por: Kügler, Johannes H., et al.
Publicado: (2015)

New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: McRae, Simon J, et al.
Publicado: (2005)

Acute on Chronic Venous Thromboembolism on Therapeutic Anticoagulation
por: Bassi, Byron, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4hmseulgns2orpqusckptjrs0r